An Acquired Abnormal Fibrinogen Associated with Thromboembolic Disease and Pseudotumor Cerebri

Summary

An abnormal fibrinogen was found in a patient associated with disabling recurrent phlebitis and pulmonary emboli, pseudotumor cerebri, gout and endometriosis. The fibrinogen is characterized by (1) abnormal side-to-side and end-to-end polymerization, (2) abnormal fibrinopeptide release, (3) a delayed γ-γ dimerization of the non cross-linked fibrin, (4) a pH optimum of 7-7.8, and (5) a deviation from normal amino acid composition with regard to lysine, aspartic acid, glutamic acid and serine. Since no defect has been found in any of her three children, and since the prothromin and partial thromboplastin times vary from time to time, it is assumed that the defect is acquired. Liver disease, usually associated with acquired abnormal fibrinogen, has been excluded as an etiological cause since liver function tests and biopsy are completely normal.

• References

• 1 Aiäch M, Rogé J, Busy MF, Durand H, Guéroult N, Chanrion Ch, Leclerc M, Justin-Besançon L. 1973; Dysfibrinogénémies acquises et affection hépatiques. A propos, de 30 observations. Sem Hop Paris 49 (03) 183
• 2 Al-Mondhiry HA B, Bilezikian SB, Nossel HL. 1975; Fibrinogen “New York”: An abnormal fibrinogen associated with thromboembolism: Functional evaluation. Blood 45: 607
• 3 Beck EA, Carache P, Jackson DP. 1964; An inherited coagulation disorder caused by an abnormal fibrinogen: Fibrinogen Baltimore. Nature 208: 143
• 4 Beck EA, Shainoff JR, Vogen A, Jackson DP. 1971; Functional evaluation of an inherited abnormal fibrinogen: Fibrinogen Baltimore. Journal of Clinical Investigation 50: 1874
• 5 Bergstöm K, WalléN P. 1961; Removal of contaminating plasminogen from purified bovine fibrinogen. Arkiv Kemi 17: 503
• 6 Blombäck B, BlombäcK M. 1956; Purification of human and bovine fibrinogen. Arkiv Kemi 10: 415
• 7 Boyer MH, Shainoff JR, Ratnoff OD. 1972; Acceleration of fibrin polymerization by calcium ions. Blood 39: 382
• 8 Brown Ill CH, Crowe MF. 1975; Defective polymerization in the conversion of fibrinogen Baltimore to fibrin. Journal of Clinical Investigation 55: 1190
• 9 Burmester HB C, Aulton K, Horsfield GI. 1970; Evaluation of a rapid method for the determination of plasma fibrinogen. American Journal of Clinical Pathology 23: 43
• 10 Cartwright T, Kekwick RG O. 1971; A comparative study of human, cow, pig and sheep fibrinogen. Biochimica et Biophysica Acta 236: 550
• 11 Davis BJ. 1964; Disc electrophoresis method and application to human serum proteins. Annals of the New York Academy of Sciences 121: 404
• 12 Donaldson VH, Kisker CT, Greive M, Rush R, Mackenzie MR. 1972. Defective thrombin-fibrinogen interaction with intermittent dysfibrinogenemia. Proceedings 3rd Congress of the International Society on Thrombosis and Haemostasis. Washington: p 82
• 13 Doolittle RF. 1973; Structural aspects of the fibrinogen to fibrin conversion. Advances in Protein Chemistry 27: 2
• 14 Dunker AK, Rueckert RR. 1969; Observations on molecular weight determinations on polyacrylamide gel. Journal of Biological Chemistry 244: 5074
• 15 Egeberg O. 1967; Inherited fibrinogen abnormality causing thrombophilia. Thrombosis et Diathesis Haemorrhagica 17: 176
• 16 Von Felten A, Straub PW, Frick PG. 1969; Dysfibrinogenemia in a patient with primary hepatoma. New Engl. Journal of Medicine 280 (08) 405
• 17 Flute PT. 1977; Disorders of plasma fibrinogen synthesis. British Medical Bulletin 33: 253
• 18 Forman WB, Ratnoff O, Boyer MH. 1968; An inherited qualitative abnormality in plasma fibrinogen: Fibrinogen Cleveland. Journal of Laboratory and Clinical Medicine 72: 455
• 19 Foster JB, De Natale A, Dotti LB. 1959; Determination of plasma fibrinogen by means of centrifugation after heating. American Journal of Clinical Pathology 31: 42
• 20 Gralnick HR, Finlayson JS. 1972; Congenital dysfibrinogenemias. Annals of Internal Medicine 77: 471
• 21 Gralnick HR, Givelber HM, Shainoff JR, Finlayson JS. 1971; Fibrinogen Bethesda: A congenital dysfibrinogenemia with delayed fibrinopeptide release. Journal of Clinical Investigation 50: 1819
• 22 Gray WR. 1972. Methods in Enzymology. In Hirs CH W, TIMASHEFF SN. (ed.) Dansyl Chloride Procedure. Academic Press; N. Y: Vol. XXVB, p. 139
• 23 Gruppo RA, Glueck HI, Granger SU, Miller MA. 1977; Platelet function in sickle cell anemia. Thrombosis Research 10: 325
• 24 Hampton JW, Garrison D. 1972; Fibrinogen and fibrin stabilizing factor. Medical Clinics of North America 56 (01) 133
• 25 Jackson DP, Beck EA, Charache P. 1965; Congenital disorders of fibrinogen. Federation Proceedings 24: 816
• 26 Jackson DP, Beck EA. 1970. Inherited Abnormal Fibrinogen. In Brinkhous K. (ed.) Hemophilia and New Hemorrhagic States. U. N. C. Press; Chapel Hill: p 225
• 27 Krantz S, Lober M. 1976; Übersicht angeborener und erworbener Varianten des Plasmafibrinogens. Folia Haematol, Leipzig 103 (06) 793
• 28 Lane DA, Scully MF, Thomas DP, Kakkar VV, Woolf IL, Williams R. 1977; Acquired dysfibrinogenemia in acute and chronic liver disease. British Journal of Haematology 35: 301
• 29 Langdell RW, Wagner RH, Brinkhous KM. 1964. Estimation of antihemophiliac activity by the partial thromboplastin technic. In Tocantins LM, Kazal LA. (ed.) Blood Coagulation, Hemorrhage and Thrombosis. Gruñe and Stratton; New York: p 103
• 30 Lewis R, Glueck HI. 1958; A micro method for determining clotting times using capillary blood and siliconized tubes. Journal of Laboratory and Clinical Medicine 52: 299
• 31 Lipinska L, Lipinski B, Gurewich M, Hoffmann KD. 1976; Fibrinogen heterogenity in cancer, in occlusive vascular disease and after surgical problems. American Journal of Clinical Pathology 66: 598
• 32 Liu IY, Chang YH. 1971; Hydrolysis of proteins with p-toluene sulfonic acid: Determination of tryptophan. Journal of Biological Chemistry 246: 2842
• 33 Lorand L. 1952; Fibrinopeptides. Biochemical Journal 52: 200
• 34 Mammen FF. Congenital abnormalities of the fibrinogen molecule. 1974; Seminars in Thrombosis and Hemostasis 1: 184
• 35 Marder VJ. 1976; The functional defects of hereditary dysfibrinogens. Thrombosis and Hamostasis 36: 1
• 36 McKee PA, Matlock P, Hill RL. 1970; Subunit structure of human fibrinogen, soluble fibrin and cross-linked insoluble fibrin. Proceedings of National Academy of Sciences (U. S.) 66: 738
• 37 Ménaché D. 1973; Abnormal fibrinogens. A Review. Thrombosis et Diathesis Haemorrhagica 29: 525
• 38 Morse D, Horecker BL. 1966; Thin-layer chromatographic separation of DNS amino acids. Analytical Biochemistry 14: 429
• 39 Mosesson MW, Beck EA. 1969; Chromatographic, ultracentrifugal, and related studies of fibrinogen “Baltimore”. Journal of Clinical Investigation 48: 1656
• 40 Murano G. 1974; Molecular Structure of Fibrinogen. Seminars in Thrombosis and Hemostasis 1: 1
• 41 Nussbaum M, Morse B. 1964; Plasma fibrin stabilizing factor in various diseases. Blood 23: 669
• 42 Ornstein L. 1964; Disc Electrophoresis I: Background and Theory. Annals of the New York Academy of Sciences 121: 321
• 43 Ponari O, Pou R. 1975; Le dysfibrinogénémie congenite et acquisite. Haematologica 60 (17) 96
• 44 Quick AJ. 1945; On the quantitiative estimation of prothrombin. American Journal of Clinical Pathology 15: 560
• 45 Ratnoff O, Forman WB. 1976; Criteria for the differentiation of dysfibrinogénémie states. Seminars in Hematology 13 (02) 141
• 46 Ratnoff O, Menzie C. 1951; A new method for determination of fibrinogen in small samples of plasma. Journal of Laboratory and Clinical Medicine 37: 316
• 47 Samama M, Soria J, Soria C, Bousser J. 1969; Dysfibrinogénèmie congénitale et familiale sans tandance hémorragique. Nouvelle Revue Française d’Hematologie 9: 817
• 48 Sherman LA, Mosesson MW, Sherry S. 1969; Isolation and characterization of the clottable low molecular weight fibrinogen derived by limited plasmin hydrolysis of human fraction 1-4. Biochemistry 8: 1515
• 49 Soria J, Coupier J, Samama M, Fixier P, Bilski-Pasquier G. 1968. Dysfibrinogenemia without bleeding tendency with abnormal polymerization of fibrin monomers in a case of severe hepatitis. XII Congress International Society of Hematology. New York: p 180
• 50 Soria J, Soria C, Samama M, Coupier J, Girard ML, Bousser J, Bliski-Pasquier G. 1970; Dysfibrinogénémias acquises dans les atteintes hépatiques sévères. Coagulation 3 (01) 37
• 51 Soulier JP. 1959; La bentonite, nouvelle absorbant des facteurs des coagulation. Revue Française d’études Cliniques at Biologiques 4 (02) 153
• 52 Stander RW, Flessa HC, Glueck HI, Kisker T. 1971; Changes in maternai coagulation factors after intra-amnionic injection of hypertonie saline. Obstetrics and Gynecology 31: 660
• 53 Verhaeghe R, Van Damme B, Molla A, Vermylin J. 1972; Dysfibrinogenemia associated with primary hepatoma. Scandinavian Journal of Haematology 9: 451
• 54 Verstraete M. 1970; Discussion. Thrombosis et Diathesis Haemorrhagica 29 Supplement 334
• 55 Weber K, Osborn M. 1969; The reliability of molecular weight determinations by dodecyl sulfate polyacrylamide gel electrophoresis. Journal Biological Chemistry 244: 4406